MicroAlgo (VENAF) Liabilities and Shareholders Equity (2020 - 2025)

MicroAlgo (VENAF) has 6 years of Liabilities and Shareholders Equity data on file, last reported at $347.2 million in Q4 2025.

• For the quarter ending Q4 2025, Liabilities and Shareholders Equity rose 96.82% year-over-year to $347.2 million; the trailing twelve-month figure through Dec 2025 stood at $958.6 million (up 132.2% YoY), and the FY2025 full-year result was $342.7 million, up 94.39% from the prior year.
• Liabilities and Shareholders Equity for Q4 2025 stood at $347.2 million, up from $327.4 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $347.2 million in Q4 2025 and bottomed at $522237.0 in Q1 2023.
• The 5-year median for Liabilities and Shareholders Equity is $57.0 million (2023), against an average of $101.5 million.
• The widest annual swing landed in 2021, when Liabilities and Shareholders Equity soared 42507.59%; it then sank 98.88% in 2023.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $81.6 million in 2021, then declined by 13.5% to $70.6 million in 2022, then decreased by 19.23% to $57.0 million in 2023, then soared by 209.4% to $176.4 million in 2024, then jumped by 96.82% to $347.2 million in 2025.
• The last three Liabilities and Shareholders Equity figures came in at $347.2 million (Q4 2025), $327.4 million (Q2 2025), and $176.4 million (Q4 2024), per Business Quant data.

Peer Comparison